Core Viewpoint - The report from CITIC Securities indicates a gradual recovery in high-end consumption in China since Q3 2025, driven by the wealth effect from rising stock markets, as evidenced by the performance of international luxury brands and the recovery of high-end shopping malls [1] Group 1: High-End Consumption Recovery - High-end consumption is expected to recover in 2026, with the timing and intensity of recovery varying by category, influenced by factors such as the proportion of VIC (Very Important Customer) clientele, the order of consumption based on wealth increase, the degree of necessity, and supply elasticity [1] - Categories with strong initial demand driven by social status and identity needs are likely to recover first, while those with a higher proportion of VIC clientele and good supply dynamics will show more sustained recovery [1] Group 2: Investment Opportunities - The report suggests that categories with strong social demand and high elasticity will benefit from the ongoing wealth effect, with those featuring more discretionary attributes expected to exhibit greater elasticity [1]

Core Viewpoint - During the "14th Five-Year Plan" period, China's economy is expected to enter a transformation phase dominated by new quality productivity, with a downward shift in growth center and intensified external geopolitical competition [1] Group 1: Investment Focus Areas - Industry investment will concentrate on four main lines: technology self-reliance driven by new quality productivity, green transformation during the carbon peak battle, the silver economy driven by an aging population, and strategic resource allocation under the coordination of development and security [1] - Non-ferrous metals are expected to maintain strong performance, with gold being a core safe-haven asset under the "de-dollarization" pricing logic, while copper and aluminum will benefit from energy transition and supply constraints [1] Group 2: Asset Allocation Strategy - The asset allocation strategy suggests a dual-peak approach: defensive allocation in high-dividend assets (such as hydropower, telecommunications operators, and state-owned banks) to secure stable cash flow returns [1] - Offensive allocation should focus on hard technology growth assets (including semiconductor equipment, industrial software, and humanoid robots) to capture excess returns from domestic substitution and industrial upgrading [1]

Core Insights - The brain-computer interface (BCI) industry in China is experiencing significant advancements, with clinical results emerging for high-level paraplegics and substantial funding rounds, including a recent 2 billion yuan investment in a non-invasive unicorn company, Strong Brain Technology, marking the second-largest funding record globally in this field [1][2] - The industry is poised for rapid commercialization, driven by technological breakthroughs, capital influx, and supportive policies, as it transitions from cutting-edge technology to practical applications in daily life [1][5] Technological Breakthroughs - Recent advancements in BCI technology include successful clinical trials for invasive systems, enabling high-level paraplegics to control smart wheelchairs and robotic dogs [2][3] - Companies like JieTi Medical and Chip Intelligence have made significant progress, with JieTi completing trials for its invasive BCI system and Chip Intelligence's semi-invasive product achieving human implantation [2][3] - The first clinical trial of a fully implanted, wireless BCI product by Brain Tiger Technology has shown promising results, allowing an 8-year paraplegic patient to achieve thought control just five days post-surgery [2][3] Policy and Capital Support - The BCI sector benefits from comprehensive policy support, including its designation as one of the six future industries in the 14th Five-Year Plan, which elevates it to a national strategic priority [5][6] - Recent initiatives by the Sichuan provincial medical insurance bureau have established pricing for 82 neuro-related medical services, including BCI applications, facilitating clinical adoption [5][6] - The establishment of industry standards by the National Medical Products Administration is expected to lower costs and risks associated with technology development and clinical application [6] Industry Collaboration and Investment - Companies like Baiyang Pharmaceutical are actively collaborating with academic institutions to explore the integration of BCI with artificial intelligence, aiming for innovative clinical solutions [7] - Other listed companies are also engaging in the BCI space through material supply and equipment development, indicating a strong interest from institutional investors [7] Future Development and Challenges - The BCI industry is anticipated to move towards standardization and scalability, with initial industry standards expected to be established by 2027-2028 [8] - Potential constraints include the pace of chip design and production, as well as the need for ethical regulations regarding personal brain data [8] - Despite these challenges, the domestic BCI industry holds significant advantages, including strong policy support, a vast clinical resource base, and a comprehensive supply chain [8] Investment Opportunities - The BCI sector presents a dual investment opportunity in both medical and technological domains, with short-term focus on disease treatment and long-term potential for enhancing human capabilities through integration with AI and robotics [9] - The industry is positioned to cultivate leading global BCI companies, fostering a capital-innovation synergy between primary and secondary markets [9]

Group 1: Federal Reserve and Employment Data - Goldman Sachs expects the Federal Reserve to maintain its current policy in January, with two rate cuts anticipated in the remainder of 2026 due to initial signs of labor market stability [1] - JPMorgan has removed its forecast for a rate cut in 2026, now predicting a 25 basis point increase in Q3 2027 [1] - Societe Generale believes the decline in unemployment and rising wages provide a stronger rationale for the Fed to hold rates steady in January [1] Group 2: Oil Prices and Geopolitical Risks - Goldman Sachs indicates that despite ongoing geopolitical risks, oil prices may continue to decline due to ample supply, predicting Brent and WTI crude oil prices to average $56 and $52 per barrel respectively in 2026 [2] Group 3: Chinese Economic Outlook - CITIC Securities forecasts a "mild re-inflation" in China in 2026, driven by a slight increase in PPI and CPI, with core CPI expected to rise due to various factors including food prices and service costs [3] - CITIC Securities also notes that the balance between external and internal demand will be crucial for the A-share market, with a higher probability of upward movement in early 2026 [4] Group 4: Commodity Prices and Market Trends - CITIC Jinpu predicts that copper prices will continue to rise, with the market not yet at an end, and expects significant support for copper prices despite short-term corrections [5] - CITIC Securities anticipates that investment in the power grid during the 14th Five-Year Plan period may reach 3.8 trillion yuan, focusing on high-quality development and stability in the energy sector [6] Group 5: Currency and Market Dynamics - Huatai Securities expects the Federal Reserve to pause rate cuts from January to May, with potential cuts occurring after the new Fed chair takes office [7] - Huachuang Securities highlights the commercialization of brain-computer interfaces, indicating a growing market with significant potential for expansion beyond the medical field [8] - Shenwan Hongyuan predicts that the RMB will appreciate by 2-3% annually over the next few years, with a total appreciation of over 30% in the next decade, benefiting the stock market [10]

香港联交所最新资料显示，1月6日，易方达基金管理有限公司减持中信建投（601066）证券 (06066)127.15万股，每股作价13.8462港元，总金额约为1760.54万港元。减持后最新持股数目约为1.13 亿股，最新持股比例为8.96%。 ...

2026年01月12日 上证公告（基金）【2026】69号 特此公告。 上海证券交易所 为促进华夏中证全指医疗器械交易型开放式指数证券投资基金（以下简称医疗器械，基金代 码:562600）的市场流动性和平稳运行，根据《上海证券交易所基金自律监管规则适用指引第2号——上 市基金做市业务》等相关规定，本所同意中信建投证券股份有限公司自2026年01月13日起为医疗器械提 供主做市服务。 ...

中信建投证券研报指出，新城控股2025全年实现商业运营总收入140.9亿元，同比增长10.0%，其中四季 度单季实现商业运营总收入35.8亿元，同比增长7.7%，全年顺利完成140亿元收入目标。截至2025年年 底，公司持有物业整体出租率为97.82%，较三季度末上升0.11 个百分点，出租率维持高位。2025年11 月公司以上海青浦吾悦广场为底层资产，成功发行6.16亿元持有型不动产ABS，标志着公司向资产运营 深化转型取得了实质性突破。公司商业运营持续向好、财务状况稳定，维持"买入"评级和21.82元的目 标价不变。 ...

Group 1 - Wan Feng Aowei's stock price increased by 3.09% to 16.99 CNY per share, with a trading volume of 1.579 billion CNY and a turnover rate of 4.41%, resulting in a total market capitalization of 36.075 billion CNY [1] - The company has experienced a continuous stock price increase for three days, with a cumulative increase of 5.33% during this period [1] - Zhejiang Wan Feng Aowei Automotive Wheel Co., Ltd. specializes in lightweight automotive metal components and general aviation aircraft manufacturing, with 80.82% of its revenue from automotive lightweight parts and 19.18% from aviation manufacturing [1] Group 2 - Citic Securities Fund holds a significant position in Wan Feng Aowei, with the Citic Securities Zhixiang Life A fund increasing its holdings by 17,600 shares to a total of 226,200 shares, representing 6.89% of the fund's net value [2] - The fund has generated a floating profit of approximately 115,400 CNY today and a total of 194,500 CNY during the three-day stock price increase [2] - The Citic Securities Zhixiang Life A fund was established on November 4, 2020, with a current scale of 33.9388 million CNY and a year-to-date return of 6.3% [2]

Group 1: Robotics Industry - The CES exhibition showcased significant advancements in humanoid robots, indicating that the industry is poised to benefit deeply from AI development. Robots are becoming crucial applications for AI, with notable confidence expressed by Elon Musk regarding the capabilities of the Optimus robot [2] - Key upcoming events include the release of Tesla's Gen3 and the IPO progress of domestic robot manufacturers, which are expected to catalyze market interest [2] Group 2: Construction Machinery - In December, excavator sales experienced double-digit growth, exceeding expectations, with a total of 23,095 units sold, marking a 19.2% year-on-year increase. Domestic sales accounted for 10,331 units (+10.9%), while exports reached 12,764 units (+26.9%) [3] - The construction machinery market is anticipated to grow by over 10% domestically and over 15% in exports in 2026, driven by strong internal and external demand [3] Group 3: Semiconductor Equipment - The IPO application of Changxin Technology has been accepted, signaling the start of a major cycle in the storage sector, with equipment orders expected to maintain high growth rates. Capital expenditures for fabs are projected to increase in 2026, particularly in the storage segment [4] Group 4: Lithium Battery Equipment - The solid-state battery sector is nearing mass production, with the introduction of the world's first all-solid-state battery by DonutLab at CES 2026. The establishment of national standards for solid-state batteries is expected to enhance industry clarity and reduce terminology confusion [5] - As mid-term evaluations for solid-state batteries proceed, the technology is expected to solidify, leading to new rounds of order tenders from leading battery and vehicle manufacturers [5] Group 5: PCB Equipment - The PCB industry is returning to an upward trend, characterized by product high-endization and factory establishment in Southeast Asia, which is expected to drive demand for PCB equipment upgrades [6] - Key segments of PCB equipment, such as drilling and plating, are critical for determining circuit board performance and reliability, with AI driving advancements in processing requirements [6] Group 6: Forklifts and Mobile Robots - Forklift sales have shown consistent growth, with domestic sales increasing by 4% and exports by 11% in November. The market for smart logistics and unmanned forklifts is expected to expand rapidly [8] Group 7: Recommended Companies in Machinery Sector - Key companies recommended for investment include Hengli Hydraulic, Obit Light, LiuGong, XCMG, and others, indicating a strong outlook for the machinery sector [9]

Group 1 - The International Telecommunication Union (ITU) reported that by December 2025, China has submitted plans for over 200,000 large-scale satellite constellations, setting a new record for satellite constellation applications in the country [1][2] - The applications include contributions from various entities such as China Satellite Network Group, Shanghai Yuanxin, and traditional telecom operators like China Mobile and China Telecom, indicating a rapid integration of satellite internet into the national information infrastructure [1][2] - According to ITU regulations, satellite frequency and orbital resources follow a "first-come, first-served" principle, requiring the first satellite to be launched within seven years of application and full deployment within nine years, which means China must launch its first satellite by the end of 2032 and complete all deployments by the end of 2039, averaging 14,300 launches per year [2] Group 2 - CITIC Securities predicts that by 2026, China will see a surge in test flights of reusable rockets, which will help reduce launch costs and increase frequency to meet the growing demand for satellite launches [3] - In 2025, China successfully completed the maiden flights of the Zhuque-3 and Long March 12A reusable rockets, although further technical iterations are needed for first-stage recovery [3] - The construction and utilization of domestic commercial rocket launch sites are expected to shorten the test flight cycle, with the total number of launches in 2026 projected to exceed 100, up from 92 in 2025, laying a solid foundation for regular reusable rocket launches [3] Group 3 - A detailed table outlines various rocket models planned for 2026, including the Long March 12A, Long March 12B, and Zhuque-3, with specific launch timelines and key information about their development status [4] - The Long March 12A has successfully completed its first flight but is currently undergoing optimization for recovery, while the Long March 12B is expected to have its maiden flight in 2026 [4] - Other models like the Long March 10 series and Zhuque-3 are also scheduled for launches in 2026, indicating a robust pipeline for China's space launch capabilities [4]